Partner news
News
Partner news
Ultromics Announces Collaboration with Janssen to Develop AI for Patients with Amyloidosis with Cardiac Involvement
Read full storyPartner news
F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics
Read full storyPartner news
Whole Genome Sequencing data on 200,000 UK Biobank participants are made widely available for research
Read full storyPartner news
Persephone Biosciences Inc. Announces Collaboration with Janssen Biotech, Inc.
Read full storyPartner news
Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development
Read full storyPartner news
Mestag Therapeutics announces collaboration with Janssen, focused on the discovery of novel fibroblast targets for the treatment of inflammatory disease
Read full storyPartner news
L'engagement de Janssen France dans l'IA et la génomique
Read full storyPartner news
Collaboration with Johnson & Johnson Innovation to jump-start search for new malaria drugs
Read full storyPartner news
Teneobio Announces Achievement of Milestone Payment as Janssen Advances Phase I Study of Bispecific JNJ-75348780 for the Treatment of NHL and CLL
Read full storyPartner news
Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza
Read full storyPartner news
Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders
Read full storyPartner news
Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement
Read full storyPartner news
Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen
Read full storyPartner news